Lunit
AI-driven cancer diagnostics and oncology solutions utilizing medical imaging data.
What they do
The company develops advanced software that analyzes mammograms, chest X-rays, and pathology slides to detect cancer markers early. They sell their diagnostic solutions to medical systems, hospitals, and pharmaceutical developers looking to optimize cancer therapy selection.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Clinical AI triage
- Product type
- Software as a medical device
- Stage
- Public
- Headquarters
- Seoul, South Korea
- Region
- Asia-Pacific
- Founded
- 2013
- Total funding
- $130M raised
Notable investors: SoftBank Ventures Asia, Legend Capital, Shinhan Card.